Acetylcholinesterase point mutations putatively associated with monocrotophos resistance in the two-spotted spider mite

被引:51
作者
Kwon, Deok Ho [1 ]
Im, Jae Seong [1 ]
Ahn, Jeong Joon [1 ]
Lee, Joon-Ho [1 ]
Clark, J. Marshall [2 ]
Lee, Si Hyeock [1 ]
机构
[1] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea
[2] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA
关键词
Acaricide; Monocrotophos; Resistance; Tetranychus urticae; Acetylcholinesterase; Point mutation; PERIPHERAL ANIONIC SITE; INSECTICIDE RESISTANCE; INHIBITION; MOSQUITO; TETRANYCHID; MECHANISMS; BINDING;
D O I
10.1016/j.pestbp.2009.08.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Molecular mechanisms of monocrotophos resistance in the two-spotted spider mite (TSSM), Tetranychus urticae Koch, were investigated. A monocrotophos-resistant strain (AD) showed ca. 3568- and 47.6-fold resistance compared to a susceptible strain (UD) and a moderately resistant strain (PyriF), respectively. No significant differences in detoxification enzyme activities, except for the cytochrome P450 monooxygenase activity, were found among the three strains. The sensitivity of acetylcholinesterase (AChE) to monocrotophos, however, was 90.6- and 41.9-fold less in AD strain compared to the UD and PyriF strains, respectively, indicating that AChE insensitivity mechanism plays a major role in monocrotophos resistance. When AChE gene (Tuace) sequences were compared, three point mutations (G228S, A391T and F439W) were identified in Tuace from the AD strain that likely contribute to the AChE insensitivity as predicted by structure analysis. Frequencies of the three mutations in field populations were predicted by quantitative sequencing (QS). Correlation analysis between the mutation frequency and actual resistance levels (LC50) of nine field populations suggested that the G228S mutation plays a more crucial role in resistance (r(2) = 0.712) compared to the F439W mutation (r(2) = 0.419). When correlated together, however, the correlation coefficient was substantially enhanced (r(2) = 0.865), indicating that both the F439W and G228S mutations may work synergistically. The A391T mutation was homogeneously present in all field populations examined, suggesting that it may confer a basal level of resistance. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 26 条
[1]   Sequence of a cDNA encoding acetylcholinesterase from susceptible and resistant two-spotted spider mite, Tetranychus urticae [J].
Anazawa, Y ;
Tomita, T ;
Aiki, Y ;
Kozaki, T ;
Kono, Y .
INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 33 (05) :509-514
[2]   Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe [J].
Chauret, N ;
Tremblay, N ;
Lackman, RL ;
Gauthier, JY ;
Silva, JM ;
Marois, J ;
Yergey, JA ;
Nicoll-Griffith, DA .
ANALYTICAL BIOCHEMISTRY, 1999, 276 (02) :215-226
[3]   ECOLOGICAL AND GENETIC-FACTORS INFLUENCING EVOLUTION OF PESTICIDE RESISTANCE IN TETRANYCHID AND PHYTOSEIID MITES [J].
CROFT, BA ;
VANDEBAAN, HE .
EXPERIMENTAL & APPLIED ACAROLOGY, 1988, 4 (03) :277-300
[4]  
ELDIN MHT, 1990, J APPL ENTOMOL, V110, P416, DOI 10.1111/j.1439-0418.1990.tb00140.x
[5]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&
[6]  
Georghiou G.P., 1991, OCCURRENCE RESISTANC
[7]   QUATERNARY LIGAND-BINDING TO AROMATIC RESIDUES IN THE ACTIVE-SITE GORGE OF ACETYLCHOLINESTERASE [J].
HAREL, M ;
SCHALK, I ;
EHRETSABATIER, L ;
BOUET, F ;
GOELDNER, M ;
HIRTH, C ;
AXELSEN, PH ;
SILMAN, I ;
SUSSMAN, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :9031-9035
[8]  
HELLE W., 1962, TIJDSCHR PLANTEZIEKTEN, V68, P155
[9]  
HOUCK MA, 1994, ECOLOGICAL EVOLUTION
[10]   The peripheral anionic site of acetylcholinesterase: Structure, functions and potential role in rational drug design [J].
Johnson, G ;
Moore, SW .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (02) :217-225